Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
In this Special Issue, we focus on maternal docosahexaenoic acid, 22:6n-3 (DHA), and arachidonic acid, 20:4n-6 (ARA), on children’s neurodevelopment. During the last trimester of gestation and for the first 18 months after birth, both DHA and ARA are preferentially deposited within the cerebral cortex at a rapid rate. The mode of action of these two fatty acids and their derivatives at different structural–functional roles, and their levels in the signaling pathways of the brain have been continuously studied. These fatty acids are also involved in various brain developmental processes; however, their mechanistic cross talks are not yet clearly known. Recent data suggest that there may be a need for a balanced proportion of ARA and DHA in infant formula due to their complementary benefits. This review describes the importance of ARA in addition to DHA to support optimal brain development and growth in an infant, and functional roles in the brain.
maternal supplementation --- pregnancy --- lactation --- docosahexaenoic acid (DHA) --- neurodevelopment --- randomized controlled trial (RCT) --- India --- DHA --- brain --- MFSD2a --- SPM --- fetus --- placenta --- infant --- neurogenesis --- pre-term --- docosahexaenoic acid --- supplementation --- egg yolk --- microalgae --- long chain omega-3 fatty acids --- pregnancy outcomes --- anthropometry --- birth weight --- birth length --- head circumference --- arachidonic acid,20:4n-6 --- docosahexaenoic acid,22:6n-3 --- maternal diet --- cognitive --- infants --- n/a
Choose an application
Metabolomics has been a useful method for various study fields. However, its application in animal science does not seem to be sufficient. Metabolomics will be useful for various studies in animal science: Animal genetics and breeding, animal physiology, animal nutrition, animal products (milk, meat, eggs, and their by-products) and their processing, livestock environment, animal biotechnology, animal behavior, and animal welfare. More application examples and protocols for animal science will promote more motivation to use metabolomics effectively in the study field. Therefore, in this Special Issue, we introduced some research and review articles for “Metabolomic Applications in Anmal Science”. The main methods used were mass spectrometry or nuclear magnetic resonance spectroscopy. Not only a non-targeted, but also a targeted, analysis of metabolites is shown. The topics include dietary and pharmacological interventions and protocols for metabolomic experiments.
albumen --- breed --- chicken --- feed --- metabolome --- yolk --- arachidonic acid --- omega-3 fatty acids --- lipidomics --- mass spectrometry --- dietary fat --- fatty acid metabolism --- pork --- meat --- skeletal muscle --- fiber type --- cooking --- beef --- Wagyu --- Holstein --- captive giraffes --- urine --- metabolomics --- 1H-NMR --- NMR --- metabotype --- transition --- ketosis --- cattle --- chemometrics --- spectral correction --- authentication --- biomarker --- feeding --- meat quality traits --- metabolite --- postmortem aging --- processing --- chickens --- heat stress --- lipid peroxidation --- orotic acid --- feed efficiency --- biomarkers --- SNPs --- GWAS --- RFI --- pigs --- pathways --- metabolic profile --- transition period --- livestock --- methyl donor --- one-carbon metabolism --- negative energy balance --- pasture legumes --- phytoestrogens --- flavonoids --- coumestans --- polyphenols --- proanthocyanidins --- metabolic profiling --- biosynthesis --- linear model --- transcriptomics --- horse --- metabolomic --- metabolism --- exercise --- saliva --- anabolic practices --- testosterone --- plasma --- CE-TOFMS --- intramuscular fat --- meat quality --- porcine
Choose an application
Oral health is general health. If the oral cavity is kept healthy, the whole body is always healthy. Bacteria in the oral cavity do not stay in the oral cavity, but rather they travel throughout the body and can induce various diseases. Periodontal pathogens are involved in tooth loss. The number of remaining teeth decreases with age. People with more residual teeth can bite food well and live longer with lower incidence of dementia. There are many viruses in the oral cavity that also cause various diseases. Bacteria and viruses induce and aggravate inflammation, and therefore should be removed from the oral cavity. In the natural world, there are are many as yet undiscovered antiviral, antibacterial and anti-inflammatory substances. These natural substances, as well as chemically modified derivatives, help our oral health and lead us to more fulfilling, high quality lives. This Special Issue, entitled "Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions", was written by specialists from a diverse variety of fields. It serves to provide readers with up-to-date information on incidence rates in each age group, etiology and treatment of stomatitis, and to investigate the application of such treatments as oral care and cosmetic materials.
gargle --- oral lichen planus --- angiotensin II blocker --- quantitative structure-activity relationship --- metabolomics --- CCN2 --- anti-human immunodeficiency virus (HIV) --- oral cell --- arachidonic acid cascade --- Kampo medicine --- lignin-carbohydrate complex --- traditional medicine --- eugenol --- QSAR analysis --- constituent plant extract --- polyphenol --- benzaldehyde --- glucosyltransferase --- infective endocarditis --- antiviral --- periodontitis --- nutritionally variant streptococci --- Kampo --- quantitative structure-activity relationship (QSAR) analysis --- traditional Japanese herbal medicine --- technical terms --- allergic rhinitis --- nasal epithelial cell --- antimicrobial susceptibilities --- alkaline extract --- mastic --- stomatitis --- thioredoxin --- production --- oral microbiota --- Jixueteng --- oral inflammation --- random forest --- mice --- chromone --- natural products --- Chinese herbal remedies --- inflammation --- quercetin --- in vivo --- kampo formula --- glucocorticoids --- Hangeshashinto --- recurrent aphthous stomatitis --- anti-osteoclast activity --- cytotoxicity --- dental application --- tongue diagnosis --- natural product --- alkaloids --- inflammatory disease --- pathogenic factors --- increase --- machine learning --- human virus --- cepharanthin --- mucositis --- oral diseases --- Juzentaihoto --- in vitro --- herbal medicine --- tumour-specificity
Choose an application
The impact of fat intake on hypercholesterolemia and related atherosclerotic cardiovascular diseases has been studied for decades. However, the current evidence base suggests that fatty acids also influences cardiometabolic diseases through other mechanisms including effects on glucose metabolism, body fat distribution, blood pressure, inflammation, and heart rate. Furthermore, studies evaluating single fatty acids have challenged the simplistic view of shared health effects within fatty acid groups categorized by degree of saturation. In addition, investigations of endogenous fatty acid metabolism, including genetic studies of fatty acid metabolizing enzymes, and the identification of novel metabolically derived fatty acids have further increased the complexity of fatty acids' health impacts. This Special Issue aims to include original research and up-to-date reviews on genetic and dietary modulation of fatty acids, and the role and function of dietary and metabolically derived fatty acids in cardiometabolic health.
coronary artery disease --- n-6 fatty acids --- ischemic heart disease --- n-3 fatty acids --- body weight --- alternatively activated macrophages --- type 2 cytokines --- children --- medium-chain triglyceride --- fat --- omega-3 PUFA --- substitution models --- obesity --- EETs --- arachidonic acid --- blood pressure --- Genome-wide association study (GWAS) --- antioxidant --- Mediterranean diet --- Insulin sensitivity --- PUFA --- n-3 PUFA --- long-chain triglyceride --- fish oil --- omega 3 --- CAD --- adipose tissue --- FADS --- blood lipids --- hemodynamics --- genotype --- erucic acid --- klotho --- CYP450 eicosanoids --- cardiometabolic disease --- fibrosis --- desaturase --- EEQs --- cohort study --- lipid metabolism --- fatty acid --- metabolic disease --- epidemiology --- omega-3 --- inflammation --- docosapentaenoic acid --- omega-6 PUFA --- type 2 diabetes mellitus --- diet --- CKD --- human --- perivascular adipose tissue --- seafood --- cardiovascular disease --- prospective cohort study --- linoleic acid --- low-fat diet --- conjugated fatty acids --- furan fatty acids --- unsaturated fat --- statins --- fish --- cholesterol ester --- CHD --- COPD
Choose an application
Unhealthy food intake and insufficient physical activities are related to obesity or lifestyle diseases, which can cause cardiovascular diseases, ultimately leading to death. However, many people are not aware of the importance of these factors, especially before cardiovascular development, although there are several good food habits that can be adopted. After the development of obesity or lifestyle diseases, nutrition and exercise control with appropriate medical therapies are required. Still, many patients do not recognize the importance of these habits. After cardiovascular disease development, nutrition and exercise with optimal medical and/or interventional therapies are required. However, some patients are not able to control their food intake and physical activities. At the advanced stage of heart failure, many things are restricted, including food intake and quality of life issues. At the end of life, nutritional care should be discussed. This book, Nutrition, Exercise, and End-of-Life Discussion in the Cardiovascular Field, addresses the importance of nutrition control before and after cardiovascular disease development, which consists of 14 peer-reviewed papers that cover the general population and patients with end-stage cardiovascular diseases.
milk intake --- mortality --- stroke --- Bayesian survival analysis --- time-to-event data --- JACC study --- unhealthy eating habits --- accumulation --- obesity --- central obesity --- general Japanese population --- atherosclerotic cardiovascular disease --- polyunsaturated fatty acids --- eicosapentaenoic acid --- docosahexaenoic acid --- arachidonic acid --- descriptive study --- heart failure --- vitamin D --- big data --- heart failure with preserved ejection fraction --- geriatric nutritional risk index --- behavioral modification stages --- nutrition counseling --- patient education --- acute coronary syndrome --- healthy behaviors --- diet --- legumes --- fish --- red/processed meat --- physical activity --- anxiety --- depression --- season --- calorie intake --- hospitalization --- malnutrition --- D-dimer --- intervention --- elderly --- cardiovascular mortality --- selenium --- coenzyme Q10 --- acylcarnitine --- brain natriuretic peptide --- cardiac function --- cardiomyopathy --- carnitine deficiency --- CPT2 --- end-stage kidney disease --- free fatty acid --- hemodialysis --- continuous glucose monitoring --- glucose fluctuation --- intracranial artery stenosis --- mean amplitude of glycemic excursions --- standard deviation --- palliative care --- end-of-life care discussion --- advance care planning --- food intake --- artificial nutrition --- onco-cardiology --- nutrition status --- cancer --- acute myocardial infarction --- plant-based dietary patterns --- grains --- nuts --- fruits --- vegetables --- cardiovascular disease --- n/a
Choose an application
Women and men have probably never been concerned as much by their health as during this COVID-19 pandemic. In this context, lifestyle habits continue to be promoted as allies for daily prevention against diseases. This is valid also for metabolic diseases, among which many affect the liver and are risk factors for aggravating the disease course of COVID-19. In fact, liver diseases are currently a major global health problem. There is a huge range of liver diseases and non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic condition, which in some patients progresses to cirrhosis and liver cancer. Currently, substantial efforts are being made to better understand NAFLD, especially, because there is no U.S. Food and Drug Administration (FDA)-approved pharmacological therapy. To explore this disease, metabolomics is the most recently developed omics technology after genomics, transcriptomics, and proteomics. Metabolomics is the large-scale analysis of molecules, known as metabolites that are intermediate or end products of metabolism found within cells, tissues, and biofluids. This technology has a very high potential to identify biomarker candidates for the future development of new therapeutics. The book features articles that address metabolomics technology and its use to document different liver functions and dysfunctions, with a major focus on NAFLD.
nonalcoholic fatty liver disease --- nonalcoholic steatohepatitis --- Fibrosis --- Liver biopsy --- Genomics --- Metabolomics --- Proteomics --- Transcriptomics --- nicotinamide --- NAFLD --- steatosis --- heat stress --- primary mouse hepatocytes --- metabolic profile --- GC-MS --- multivariate statistical analysis --- arachidonic acid --- docosahexaenoic acid --- inflammation --- fibrosis --- lipidomics --- mass spectrometry --- in vitro --- HepaRG --- sodium saccharin --- reference toxicants --- de novo lipogenesis --- carbohydrate response element-binding protein --- ChREBP --- diabetes --- glucose production --- glycogen --- glycolysis --- glycogen storage disease type I --- hexosamine --- pentose phosphate pathway --- acupuncture --- imflammation --- lipid metabolism --- oxidative stress --- metabolomics quantitative profiling --- 1H-NMR spectroscopy --- liver --- bile acids --- metabolomics --- rat plasma --- tandem mass spectrometry --- liquid chromatography --- acetaminophen --- hepatotoxicity --- biomarker --- premalignant --- alcoholic liver disease --- cholestasis --- cirrhosis --- NAFL --- NASH --- standard operating procedures --- urine --- blood --- feces --- tissue --- cells --- liver function --- nonalcoholic fatty liver --- liquid chromatography-mass spectrometry --- nuclear magnetic resonance spectroscopy --- metabolic pathway --- non-alcoholic fatty liver disease --- non-alcoholic steatohepatitis --- transcription factors --- metabolic stress --- lipid homeostasis --- glucose homeostasis
Choose an application
Phospholipases are a ubiquitous group of enzymes that hydrolyze ester bonds within membrane phospholipids. These enzymes serve multiple biological functions that go far beyond a mere membrane remodeling role in cellular homeostasis; they also play key functions in nutrient digestion and the regulated formation of bioactive lipids involved in cell signaling. It is to the latter function, critical to life, that this book is primarily concerned with. All the chapters are written by renowned experts in the area, and provide forefront information on the role phospholipases in a number of physiological and pathophysiological settings.
inhibitor --- metabolic stability --- α-methylation --- oxoesters --- phospholipase A2 --- adrenic acid --- arachidonic acid --- mass spectrometry --- lipid signaling --- inflammation --- monocytes/macrophages --- crotoxin --- snake venom --- lung impairment --- inflammatory response --- lipid mediators --- neuromuscular blocker --- lipidomics --- PAP-2 --- autotaxin --- lysophosphatidate --- G protein-coupled receptor --- PLA2G6 --- fatty liver --- phospholipid remodeling --- diet-induced obesity --- morbidly obesity --- choline and methionine deficiency --- glioblastoma --- sphingolipid --- sphingosine-1-phosphate --- sphingomyelinase --- sphingomyelin --- metastasis --- phosphatidic acid --- diacylglycerol --- lipin --- signaling --- cPLA2α --- psoriasis --- proliferation --- anti-inflammatory --- atherosclerosis --- phospholipases --- macrophages --- T cells --- lipins --- pancreatic islets --- β-cells --- insulin secretion --- glucose tolerance --- insulin resistance --- group VIA phospholipase A2 --- fatty acid --- knockout mouse --- lipid mediator --- lysophospholipid --- membrane --- phospholipid --- ceramide --- acidic sphingomyelinase --- neutral sphingomyelinase --- hepatocellular carcinoma --- alcoholic and nonalcoholic steatohepatitis --- preadipocytes --- prostaglandins --- adipokines --- cytokines --- EP receptors --- Group V phospholipase A2 --- lipids --- majeed syndrome --- LPIN2 --- LIPIN2 --- chronic non-bacterial osteomyelitis --- chronic recurrent multifocal osteomyelitis --- autoinflammatory --- inflammasome --- macrophage --- osteoclast --- n/a
Choose an application
Human lactation has evolved to produce a milk composition that is uniquely-designed for the human infant. Not only does human milk optimize infant growth and development, it also provides protection from infection and disease. More recently, the importance of human milk and breastfeeding in the programming of infant health has risen to the fore. Anchoring of infant feeding in the developmental origins of health and disease has led to a resurgence of research focused in this area. Milk composition is highly variable both between and within mothers. Indeed the distinct maternal human milk signature, including its own microbiome, is influenced by environmental factors, such as diet, health, body composition and geographic residence. An understanding of these changes will lead to unravelling the adaptation of milk to the environment and its impact on the infant. In terms of the promotion of breastfeeding, health economics and epidemiology is instrumental in shaping public health policy and identifying barriers to breastfeeding. Further, basic research is imperative in order to design evidence-based interventions to improve both breastfeeding duration and women's breastfeeding experience.
Cambodia --- milk metabolomics --- galactogogues --- adequate intake --- postnatal outcomes --- cytomegalovirus --- midwifery --- milk synthesis --- chromatography --- protein --- lactoferrin --- human lactation --- ultrasound skinfolds --- breastfed infants --- knowledge --- pregnancy --- casein --- SEA --- maternal factors --- ethnicity --- post-partum distress --- bottle --- composition --- feeding --- co-sleeping --- passive immunity --- glycerophosphocholine --- anthropometrics --- antimicrobial proteins --- professional support --- mothers of preterm infants --- responsive feeding --- lactating women --- peptidomics --- triiodothyronine --- preterm --- mother–infant physical contact --- expressing --- preterm infant --- appetite regulation --- justification of supplementation --- body composition --- zinc supplementation --- antibodies --- antisecretory factor --- proteolysis --- enteral nutrition --- Ecuador --- growth factors --- maternal responsiveness --- maternal wellbeing --- nipple shield --- microbiome --- maternal distress --- sodium --- thyroid --- maternal diet --- thyroxine --- IgA --- caesarean section --- raw breast milk --- colostrum --- fatty acids --- breast milk --- immune cells --- metabolites --- PEA --- premature --- mode of delivery --- endocannabinoids --- lipids --- practice --- fat synthesis --- attitudes --- feeding cues --- infant --- Docosahexaenoic acid --- Arachidonic acid --- GDM --- milk-acquired infections --- zinc deficiency --- ICP-OES --- social support --- infants --- omega-6 fatty acids --- infant health --- HGF --- omega-3 fatty acids --- OEA --- leptin --- milk metabolites --- Canada --- mother–infant interaction --- NMR spectroscopy --- lipidomics --- infection --- breastfeeding support --- prematurity --- phosphocholine --- immunity --- Quito --- sex-specificity --- choline --- paternal role --- inflammation --- docosahexaenoic acid --- partner support --- proximal care --- thyroid antibodies --- adipokines --- calculated daily intakes --- candida --- proton nuclear magnetic resonance --- N-acylethanolamines --- milk intake --- whey --- bioelectrical impedance spectroscopy --- breastfeeding --- n-6 and n-3 polyunsaturated fatty acid --- babywearing --- milk composition --- breastmilk --- obesity --- lactation --- infant growth --- formula supplementation --- early life nutrition --- adiponectin --- milk cells --- potassium --- human milk --- long-chain polyunsaturated fatty acids --- Andean region --- Ireland --- mass spectrometry --- geographical location --- diet --- dietary recommendations --- TGF-? --- ion selective electrode --- plasma zinc --- barriers --- infant feeding --- human milk composition --- Breastfeeding
Choose an application
Human milk is uniquely tailored to meet infants’ specific nutritional requirements. However, it is more than just “milk”. This dynamic and bioactive fluid allows mother–infant signalling over lactation, guiding the infant in the developmental and physiological processes. It exerts protection and life-long biological effects, playing a crucial role in promoting healthy growth and optimal cognitive development. The latest scientific advances have provided insight into different components of human milk and their dynamic changes over time. However, the complexity of human milk composition and the synergistic mechanisms responsible for its beneficial health effects have not yet been unravelled. Filling this knowledge gap will shed light on the biology of the developing infant and will contribute to the optimization of infant feeding, particularly that of the most vulnerable infants. Greater understanding of human milk will also help in elucidating the best strategies for its storage and handling. The increasing knowledge on human milk’s bioactive compounds together with the rapidly-advancing technological achievements will greatly enhance their use as prophylactic or therapeutic agents. The current Special Issue aims to welcome original works and literature reviews further exploring the complexity of human milk composition, the mechanisms underlying the beneficial effects associated with breastfeeding, and the factors and determinants involved in lactation, including its promotion and support.
high pressure processing --- n/a --- lipids --- supplementation --- protective factors --- infant --- carbohydrate --- mothers --- antioxidant capacity --- protein --- fat --- cytokines --- bioactive factors --- late preterm --- zinc --- infants --- docosahexaenoic acid (DHA) --- pregnancy --- eicosapentaenoic acid (EPA) --- Lipidomics --- magnesium --- omega-3 fatty acids --- vitamin D deficiency --- flow injection analysis --- human milk benefits --- multiple source method --- 3?-sialyllactose (3?SL) --- milk banking --- milk group --- pasteurization --- video instruction --- Milk Fat Globule Membrane --- bile salt stimulated lipase --- breastfeeding difficulties --- breastfeeding support --- prematurity --- carotenoids --- hormones --- phosphocholine --- amino acids --- targeted metabolomics --- high-performance liquid chromatography (HPLC) --- choline --- selenium --- ?-linolenic acid --- arachidonic acid (ARA) --- docosahexaenoic acid --- human milk fortification --- protease inhibitors --- celiac disease --- copper --- term --- adipokines --- iodine --- mammary gland --- nutritional status --- food frequency questionnaire --- neonate --- early breastfeeding cessation --- prospective study --- breastfeeding --- mothers’ own milk --- disialyllacto-N-tetraose (DSLNT) --- country --- lactating women --- undernourishment --- proteases --- preterm --- expressing --- dietary assessment --- retinol --- body composition --- duration of lactation --- passive immunization --- 2?-fucosyllactose (2?FL) --- phosphorus --- clinical trial --- growth factors --- infant formula --- digestive tract --- human milk oligosaccharides (HMO) --- sodium --- nutrition --- eicosapentaenoic acid --- lipid metabolites --- lactation --- nervonic acid --- ?-tocopherol --- macronutrients --- glycoprotein --- term infant --- term infants --- maternal diet --- promotion of breastfeeding --- potassium --- antioxidants --- maternal immunoglobulins --- Human Milk --- human milk --- Phospholipids --- flu vaccine --- lactational stage --- lactose --- storage --- dietary intake --- Preterm infant --- immune-active proteins --- colostrum --- human milk fat --- inadequate intake --- milk therapy --- endogenous peptide --- calcium --- fatty acids --- breast milk --- pumping --- secretor --- LC-MS --- n-9 fatty acid --- Lewis --- donor human milk --- antenatal --- online --- iron --- growth --- donor milk --- mothers' own milk
Choose an application
Supporting initiation, development and resolution of appropriate immune responses is key to survival. Many nutrients and dietary components have been purported to have a role in supporting optimal immune function. This is vital throughout the life course, from the development and programming of the immune system in early life, to supporting immunity and reducing chronic inflammation in older people. In this special issue of Nutrients, we examine the evidence for the role of diet and dietary components in promoting protective immunity.
immunonutrition --- supplementation --- superoxide dismutase (SOD) --- fermented milk --- selenocysteine --- dendritic cells --- lipoxygenase (LOX) --- chronic inflammatory conditions --- formulation --- immune system --- cytokines --- skeletal muscle --- zinc --- non-digestible carbohydrates --- Toll-like receptor --- carbohydrates --- fiber --- lymphocytes --- antibody --- infants --- liver --- macrophage --- inflammatory process --- probiotic --- plant --- older people --- gut barrier --- infection --- amino acids --- gut --- T helper 1 (Th1) --- immunity --- T cells --- bioactive peptide --- inhibitor of kappa kinase (IKK) --- inflammation --- adhesion molecules --- leukocytes --- human milk oligosaccharides --- vitamin D --- food structure --- vitamin E --- mitogen-activated protein Kinase (MAPK) --- gut microbiota --- weaning --- homeostasis --- intestinal immune system --- extra-cellular signal regulated kinases (ERK) --- cyclooxygenase (COX) --- oxidative stress --- life course --- polyphenols --- oligosaccharides --- micronutrients --- Th17 --- obesity --- tolerance --- arachidonic acid --- growth factors --- anti-inflammation --- age-related immunity --- prebiotic --- biomarker --- microbiome --- functional foods --- immunosenescence --- nutrition --- molecular mechanisms --- metabolism --- macronutrients --- toll-like receptor 4 --- sepsis --- nutrition guidelines --- microbiota --- immunomodulation --- inflammatory markers --- elderly --- Th1/Th17 response --- adults --- reactive oxygen species (ROS) --- anorexia nervosa --- macrophages --- autoimmune diseases --- fatty acids --- T cell --- Treg --- breast milk --- nitric oxide synthase (NOS) --- chemokines --- anti-tumorigenic --- metabolites --- deficiency --- protein hydrolysate --- nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) --- cancer
Listing 1 - 10 of 13 | << page >> |
Sort by
|